This Week in RadOnc - Vol. 3, October 16th, 2026
Volume 3, October 16th, 2026 Welcome back to This Week in Rad Onc! This week’s evidence asks where precision adds value—and where promising technology still needs validation. ROAM strengthens the discussion of postoperative radiation for atypical meningioma, while ASTRO updates bring longer follow-up and important cautions about toxicity, crossover and local control. For treatment teams, new CBCT and electron-dosimetry studies sit alongside practical motion-management guidance. We also...